NM_181351.5:c.53-81483G>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181351.5(NCAM1):​c.53-81483G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0856 in 152,198 control chromosomes in the GnomAD database, including 729 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.086 ( 729 hom., cov: 32)

Consequence

NCAM1
NM_181351.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.531

Publications

17 publications found
Variant links:
Genes affected
NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NCAM1NM_181351.5 linkc.53-81483G>T intron_variant Intron 1 of 19 ENST00000316851.12 NP_851996.2 P13591-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NCAM1ENST00000316851.12 linkc.53-81483G>T intron_variant Intron 1 of 19 5 NM_181351.5 ENSP00000318472.8 P13591-2

Frequencies

GnomAD3 genomes
AF:
0.0855
AC:
13010
AN:
152080
Hom.:
728
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0302
Gnomad AMI
AF:
0.110
Gnomad AMR
AF:
0.0705
Gnomad ASJ
AF:
0.0891
Gnomad EAS
AF:
0.116
Gnomad SAS
AF:
0.0658
Gnomad FIN
AF:
0.169
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.109
Gnomad OTH
AF:
0.0755
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0856
AC:
13025
AN:
152198
Hom.:
729
Cov.:
32
AF XY:
0.0891
AC XY:
6629
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0303
AC:
1257
AN:
41550
American (AMR)
AF:
0.0704
AC:
1077
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0891
AC:
309
AN:
3468
East Asian (EAS)
AF:
0.117
AC:
604
AN:
5168
South Asian (SAS)
AF:
0.0669
AC:
323
AN:
4828
European-Finnish (FIN)
AF:
0.169
AC:
1789
AN:
10580
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.109
AC:
7390
AN:
67992
Other (OTH)
AF:
0.0781
AC:
165
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
597
1194
1790
2387
2984
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0926
Hom.:
2808
Bravo
AF:
0.0736
Asia WGS
AF:
0.0820
AC:
287
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
4.1
DANN
Benign
0.81
PhyloP100
0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1436109; hg19: chr11-112991618; API